Posters presented at the 2023 Fall Clinical Dermatology Conference evaluated how label warnings may affect new treatment initiation and real-word switching patterns for patients starting risankizumab.

I’ve written several posts on different aspects of MPLS: How the FEC is key to the separation of control and forwarding functions in MPLS, the difference between implicit and explicit null labels, how ...